Loading…

LeMaitre Vascular, Inc. acquired the business and assets of Artegraft, Inc., which processes and sells biologic vascular grafts. The deal includes $90 million upfront plus potential earnout payments of $17.5 million.
“We are pleased to add Artegraft to our product offering, augmenting the suite of biologic and dialysis access products used by our core customer, the vascular surgeon.”evtoday.com
Summarized from public sources; check the original articles before acting on it.